BIOLOGICAL · Unmapped registry intervention
ganitumab
Find medicine records ·
Find other trials using this name
Clinical trial
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
NCT00562380
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
pharmacological study
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
biopsy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lymphomaverified · MONDO: lymphoma
Prostate Cancerverified · MONDO: prostate cancer
Sarcomaverified · MONDO: sarcoma
Interventions
Sponsors & collaborators
Amgenlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00562380 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.